Stock Analysis
- China
- /
- Life Sciences
- /
- SHSE:688131
Private companies among Shanghai Haoyuan Chemexpress Co., Ltd.'s (SHSE:688131) largest stockholders and were hit after last week's 6.2% price drop
Key Insights
- Shanghai Haoyuan Chemexpress' significant private companies ownership suggests that the key decisions are influenced by shareholders from the larger public
- 52% of the business is held by the top 6 shareholders
- 22% of Shanghai Haoyuan Chemexpress is held by Institutions
To get a sense of who is truly in control of Shanghai Haoyuan Chemexpress Co., Ltd. (SHSE:688131), it is important to understand the ownership structure of the business. And the group that holds the biggest piece of the pie are private companies with 40% ownership. That is, the group stands to benefit the most if the stock rises (or lose the most if there is a downturn).
As market cap fell to CN¥7.3b last week, private companies would have faced the highest losses than any other shareholder groups of the company.
In the chart below, we zoom in on the different ownership groups of Shanghai Haoyuan Chemexpress.
View our latest analysis for Shanghai Haoyuan Chemexpress
What Does The Institutional Ownership Tell Us About Shanghai Haoyuan Chemexpress?
Many institutions measure their performance against an index that approximates the local market. So they usually pay more attention to companies that are included in major indices.
As you can see, institutional investors have a fair amount of stake in Shanghai Haoyuan Chemexpress. This can indicate that the company has a certain degree of credibility in the investment community. However, it is best to be wary of relying on the supposed validation that comes with institutional investors. They too, get it wrong sometimes. If multiple institutions change their view on a stock at the same time, you could see the share price drop fast. It's therefore worth looking at Shanghai Haoyuan Chemexpress' earnings history below. Of course, the future is what really matters.
We note that hedge funds don't have a meaningful investment in Shanghai Haoyuan Chemexpress. Shanghai Anxu Information Technology Co., Ltd. is currently the largest shareholder, with 32% of shares outstanding. With 7.1% and 4.0% of the shares outstanding respectively, Junxin (Shanghai) Equity Investment Fund Management Co., Ltd. and Shanghai Chenxiao Enterprise Management Consulting Center (Limited Partnership) are the second and third largest shareholders.
We also observed that the top 6 shareholders account for more than half of the share register, with a few smaller shareholders to balance the interests of the larger ones to a certain extent.
While it makes sense to study institutional ownership data for a company, it also makes sense to study analyst sentiments to know which way the wind is blowing. There are plenty of analysts covering the stock, so it might be worth seeing what they are forecasting, too.
Insider Ownership Of Shanghai Haoyuan Chemexpress
The definition of an insider can differ slightly between different countries, but members of the board of directors always count. The company management answer to the board and the latter should represent the interests of shareholders. Notably, sometimes top-level managers are on the board themselves.
Insider ownership is positive when it signals leadership are thinking like the true owners of the company. However, high insider ownership can also give immense power to a small group within the company. This can be negative in some circumstances.
Our data suggests that insiders own under 1% of Shanghai Haoyuan Chemexpress Co., Ltd. in their own names. However, it's possible that insiders might have an indirect interest through a more complex structure. Keep in mind that it's a big company, and the insiders own CN¥8.3m worth of shares. The absolute value might be more important than the proportional share. It is good to see board members owning shares, but it might be worth checking if those insiders have been buying.
General Public Ownership
The general public, who are usually individual investors, hold a 30% stake in Shanghai Haoyuan Chemexpress. While this size of ownership may not be enough to sway a policy decision in their favour, they can still make a collective impact on company policies.
Private Equity Ownership
Private equity firms hold a 7.1% stake in Shanghai Haoyuan Chemexpress. This suggests they can be influential in key policy decisions. Some might like this, because private equity are sometimes activists who hold management accountable. But other times, private equity is selling out, having taking the company public.
Private Company Ownership
We can see that Private Companies own 40%, of the shares on issue. It's hard to draw any conclusions from this fact alone, so its worth looking into who owns those private companies. Sometimes insiders or other related parties have an interest in shares in a public company through a separate private company.
Next Steps:
I find it very interesting to look at who exactly owns a company. But to truly gain insight, we need to consider other information, too. Case in point: We've spotted 1 warning sign for Shanghai Haoyuan Chemexpress you should be aware of.
If you are like me, you may want to think about whether this company will grow or shrink. Luckily, you can check this free report showing analyst forecasts for its future.
NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.
New: Manage All Your Stock Portfolios in One Place
We've created the ultimate portfolio companion for stock investors, and it's free.
• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About SHSE:688131
Shanghai Haoyuan Chemexpress
Researches, develops, and manufactures pharmaceutical intermediates and small molecule drugs.